• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 444-458 of 645 results

1563 Exhibit: How Increased Competition From Generic Drugs has Affected Prices...

Document IPR2017-00190, No. 1563-212 Exhibit - How Increased Competition From Generic Drugs has Affected Prices and Returns in the Pharmaceutical Industry a CBO Study (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1554 Exhibit: Valeant Pharmaceuticals International, Inc, US Securities and Excha...

Document IPR2017-00190, No. 1554-203 Exhibit - Valeant Pharmaceuticals International, Inc, US Securities and Exchange Commission Form 10 K, for the Fiscal Year Ended December 31, 2016 (P.T.A.B....

cite Cite Document
Analyze

2027 Exhibit: Kaken Exhibit 2027

Document IPR2017-00190, No. 2027-74 Exhibit - Kaken Exhibit 2027 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2051 Exhibit: Kaken Exhibit 2051

Document IPR2017-00190, No. 2051-98 Exhibit - Kaken Exhibit 2051 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1021 Exhibit: Mertin, D, Journal of Pharmacy and Pharmacology, 491 30 34 1997

Document IPR2017-00190, No. 1021-21 Exhibit - Mertin, D, Journal of Pharmacy and Pharmacology, 491 30 34 1997 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

2041 Exhibit: Kaken Exhibit 2041

Document IPR2017-00190, No. 2041-88 Exhibit - Kaken Exhibit 2041 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1031 Exhibit: Summerbell, RC, Dermatology, 194 Supp 1 32 36 1997

Document IPR2017-00190, No. 1031-31 Exhibit - Summerbell, RC, Dermatology, 194 Supp 1 32 36 1997 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1638 Exhibit: Top 200 Brand Name Drugs by Retail Sales in 2000

Document IPR2017-00190, No. 1638-287 Exhibit - Top 200 Brand Name Drugs by Retail Sales in 2000 (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2076 Exhibit: Kaken Exhibit 2076

Document IPR2017-00190, No. 2076-122 Exhibit - Kaken Exhibit 2076 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1004 Exhibit: Orange Book Excerpt for Valeant¿¿¿s Jublia

Document IPR2017-00190, No. 1004-4 Exhibit - Orange Book Excerpt for Valeant¿¿¿s Jublia (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1543 Exhibit: Exhibit 1543a ¿¿¿Is Walgreens Valeant¿¿¿s New Philidor¿¿¿ D A Hussar, ...

Document IPR2017-00190, No. 1543-331 Exhibit - Exhibit 1543a ¿¿¿Is Walgreens Valeant¿¿¿s New Philidor¿¿¿ D A Hussar, The Pharmacist Activist, vol 11, no 2 February 2016 (P.T.A.B. Jan. 5, 2018)

cite Cite Document
Analyze

1611 Exhibit: Valeant Pharmaceuticals International, Inc Fourth Quarter Preliminar...

Document IPR2017-00190, No. 1611-260 Exhibit - Valeant Pharmaceuticals International, Inc Fourth Quarter Preliminary Unaudited Financial Results 2015 Conference Call Presentation, dated March 15, ...

cite Cite Document
Analyze

1597 Exhibit: Promotional spending for prescription drugs

Document IPR2017-00190, No. 1597-246 Exhibit - Promotional spending for prescription drugs (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2030 Exhibit: Kaken Exhibit 2030

Document IPR2017-00190, No. 2030-77 Exhibit - Kaken Exhibit 2030 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1039 Exhibit: Walters, KA, J Invest Dermatol, 76 76 79 1981

Document IPR2017-00190, No. 1039-39 Exhibit - Walters, KA, J Invest Dermatol, 76 76 79 1981 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 30 31 32 33 34 ... >>